<SEC-DOCUMENT>0001437749-11-009079.txt : 20111130
<SEC-HEADER>0001437749-11-009079.hdr.sgml : 20111130
<ACCEPTANCE-DATETIME>20111130105128
ACCESSION NUMBER:		0001437749-11-009079
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20111129
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20111130
DATE AS OF CHANGE:		20111130

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIO KEY INTERNATIONAL INC
		CENTRAL INDEX KEY:			0001019034
		STANDARD INDUSTRIAL CLASSIFICATION:	COMPUTER COMMUNICATIONS EQUIPMENT [3576]
		IRS NUMBER:				411761861
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13463
		FILM NUMBER:		111232935

	BUSINESS ADDRESS:	
		STREET 1:		3349 HIGHWAY 138
		STREET 2:		BUIDING D, SUITE B
		CITY:			WALL
		STATE:			NJ
		ZIP:			07719
		BUSINESS PHONE:		6516870414

	MAIL ADDRESS:	
		STREET 1:		3349 HIGHWAY 138
		STREET 2:		BUIDING D, SUITE B
		CITY:			WALL
		STATE:			NJ
		ZIP:			07719

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SAC TECHNOLOGIES INC
		DATE OF NAME CHANGE:	19961115
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>biokey_8k-112511.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<html>
<head>
    <title>biokey_8k-112511.htm</title>
    <!--Licensed to: EdgarEdge-->
    <!--Document Created using EDGARizerAgent 5.4.0.0-->
    <!--Copyright 1995 - 2009 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold">UNITED STATES</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold">SECURITIES AND EXCHANGE COMMISSION</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt">Washington, D.C. 20549</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold">FORM 8-K</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold">CURRENT REPORT</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Pursuant to Section&#160;13 or 15(d) of the Securities Exchange Act of 1934</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Date of Report (Date of earliest event reported): November 29, 2011</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td colspan="3" valign="top" width="80%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 18pt; FONT-WEIGHT: bold">BIO-key International, Inc.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Exact name of registrant as specified in its charter)</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
</td>
</tr><tr>
<td valign="top" width="27%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Delaware</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(State or other jurisdiction of incorporation)</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
</td>
<td valign="top" width="27%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">1-13463</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Commission File Number)</font></div>
</td>
<td valign="top" width="27%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">41-1741861</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(I.R.S. Employer Identification No.)</font></div>
</td>
</tr><tr>
<td colspan="3" valign="top" width="80%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">3349 Highway 138, Building D, Suite B</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Wall, NJ 07719</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Address of principal executive offices)</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
</td>
</tr><tr>
<td colspan="3" valign="top" width="80%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(732)&#160;359-1100</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Registrant&#8217;s telephone number, including area code)</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
</td>
</tr><tr>
<td align="left" colspan="3" valign="top" width="80%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<font style="FONT-STYLE: italic; DISPLAY: inline">see</font> General Instruction A.2 below):</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font> Pre-commencement communications pursuant to Rule 13e-4(c) under Exchange Act (17 CFR 240.13e-4(c))</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%">&#160;</div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Item 7.01.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Regulation FD Disclosure.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On November 29, 2011, BIO-key International, Inc. (the &#8220;Company&#8221;) issued a press release regarding a pending acquisition. &#160;A copy of this press release is attached as Exhibit 99.1.</font></font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The information, including the exhibit attached hereto, in this Current Report on Form 8-K shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as otherwise expressly stated in such filing.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Item 9.01.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Financial Statements, Pro Forma Financial Information and Exhibit.</font></div>

<div style="LINE-HEIGHT: 1.25">&#160;</div>

<div style="LINE-HEIGHT: 1.25" align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="LINE-HEIGHT: 1.25; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr style="LINE-HEIGHT: 1.25;">
<td width="5%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(d)</font></td>
<td width="95%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exhibits</font></td>
</tr><tr>
<td width="5%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="95%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td width="5%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">99.1</font></td>
<td width="95%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Press Release, dated November 29, 2011, issued by <font style="DISPLAY: inline; FONT-FAMILY: times new roman">the Company.</font></font></td>
</tr></table>
</div>

<div align="center">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">2</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">SIGNATURES</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">
<div>
<table border="0" cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="top" width="38%">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: normal">BIO-KEY INTERNATIONAL, INC.</font></font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font></div>
</td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="35%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="top" width="50%" style="BORDER-BOTTOM: #ffffff solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Date: November 30, 2011</font></div>
</td>
<td valign="top" width="3%" style="BORDER-BOTTOM: #ffffff solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">By: </font></div>
</td>
<td align="left" nowrap valign="top" width="35%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">/s/&#160;<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cecilia C. Welch</font></font></td>
<td valign="top" width="12%" style="BORDER-BOTTOM: #ffffff solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" nowrap valign="bottom" width="35%">
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cecilia C. Welch</font></font></div>
</td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="35%">
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Chief Financial Officer</font></font></div>
</td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">3</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">EXHIBIT INDEX</font></div>

<div align="center">&#160;</div>
</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 108pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Exhibit No.</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Description</font></font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 108pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">99.1</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Press Release, dated <font style="DISPLAY: inline; FONT-FAMILY: times new roman">November 29, 2011, issued by </font>the Company.</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">4</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex99-1.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<html>
<head>
    <title>ex99-1.htm</title>
    <!--Licensed to: EdgarEdge-->
    <!--Document Created using EDGARizerAgent 5.4.0.0-->
    <!--Copyright 1995 - 2009 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div style="TEXT-ALIGN: right"><font style="FONT-WEIGHT: bold">Exhibit 99.1</font></div>

<div>&#160;</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td rowspan="2" width="50%"><img src="biokeylogo.jpg" alt=""></td>
<td colspan="2" width="5%">

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 24pt; FONT-WEIGHT: bold">NEWS RELEASE</font></font></font></div>
</td>
</tr><tr>
<td valign="top" width="8%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Contacts: </font></td>
<td valign="top" width="42%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">BIO-key International, Inc.</font></font></font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Scott Mahnken</font></font></div>

<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">732-359-1113</font></font></div>
</div>
</td>
</tr></table>
</div>

<div><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold">&#160;</font></div>

<div>
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold">BIO-key International&#174; and SIC Biometrics end Merger Discussions and Enter into a Reseller Partnership Agreement</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">WALL, NJ, November 29, 2011 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (OTCBB: BKYI.OB), a global leader in finger biometric identification technology solutions announced that after careful consideration,&#160;&#160;S.I.C. Biometrics and BIO-key have decided to end&#160;&#160;plans to merge; instead BIO-key and S.I.C. have entered into a reseller partnership agreement to closely collaborate on a number of tactical business opportunities.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The partnership enables the two companies to resell products, services and solutions in a cooperative manner thus&#160;&#160;strengthening BIO-key&#8217;s and S.I.C.&#8217;s overall market reach by expanding opportunities for new projects and partnerships that will offer&#160;&#160;complete solutions for mobility and access control to business and Government customers.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Commenting on the developments, Mike DePasquale, BIO-key CEO said, &#8220;Our primary goal is to increase shareholder value. The Reseller arrangement enables us to get most of the operating benefits of a merger while avoiding any cost or shareholder dilution.&#8221;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#8220;BIO-key is committed to pioneering the gateway for biometrics to provide a secure path to mobility and the advanced functionality of Smartphone&#8217;s and Tablet devices.&#160;&#160;On a daily basis we&#8217;re seeing indications that the Smartphone&#8217;s and Tablet PC will be the most valuable and most utilized technology for consumers and businesses moving forward.&#160;&#160;Your phone will be your credit card, your passport, your bank and your shopping mall.&#160;&#160;Businesses will be using both phones and tablets to process orders and manage inventory.&#160;&#160;Advanced functionality is going to require a stronger degree of authentication &#8211; identification and
security.&#160;&#160;&#160;Our hardware independent, universal access software for iOS, Android and WinMobile devices that is easily integrated into existing desktop and laptop deployments is the best choice for companies looking to add the convenient security that finger biometrics offers. Our partnership with S.I.C. for mobile and physical access hardware solutions will help expand our reach in the market,&#8221; stated DePasquale.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#8220;We are committed to our partnership with BIO-key for our mutual success&#8221; said Eric Talbot, CEO and founder of S.I.C. Biometrics Inc. &#8220;At S.I.C.&#160;Biometrics,&#160;we strongly believe that mobile security solutions should be available to every type of users in a simple, efficient and affordable manner. I am proud to say that our unparallel mobile solutions deliver this and more to Apple users around the world and we will continue to bring smart technologies and processes to maintain our leader position of this market&#8221;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">About BIO-key</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">BIO-key International, Inc., headquartered in Wall, New Jersey, develops and delivers advanced identification solutions to commercial and government enterprises, integrators, and custom application developers.&#160;BIO-key&#8217;s award winning, high performance, scalable, cost-effective and easy-to-deploy biometric finger identification technology accurately identifies and authenticates users of wireless and enterprise applications. Our solutions are used in local embedded OEM products as well as some of the world&#8217;s largest identification deployments to improve security, guarantee identity, and help reduce identity theft.&#160;&#160;BIO-key&#8217;s technology is offered directly or by
market leading partners around the world. (<font style="DISPLAY: inline; FONT-WEIGHT: bold">http://www.bio-key.com</font>)</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; COLOR: #232323; FONT-SIZE: 10pt; FONT-WEIGHT: bold">About S.I.C. Biometrics</font></div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">S.I.C Biometrics Inc. Located in Montreal Canada and France is a 12 year old firm specialized in innovative biometrics solutions. Software developer and hardware manufacturer, S.I.C Biometrics provides worldwide state-of-the-art biometric fingerprint readers, biometric proximity cards and access control solutions to the commercial and government markets. S.I.C. Biometrics through direct collaboration with Apple in 2009 was the first to launch its unique platform of software and hardware fingerprint reader solutions for the Apple&#8217;s iPhone 3 and in 2010 launched its iPad version. Today S.I.C Biometrics offers business grade solutions for iPhone 4, iPad and recently launched a consumer
product for the Apple iPhone 4. The S.I.C Biometrics Inc. suite of products and solutions are compatible with most existing IT infrastructures providing an optimum return on investment and respecting industry standards and compliances. (<font style="DISPLAY: inline; FONT-WEIGHT: bold">http://www.sic.ca</font>)</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">BIO-key Safe Harbor Statement</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Certain statements contained in this press release may be construed as "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act").&#160; The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements.&#160; Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act.&#160; These statements are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on
the basis of these statements.&#160; These risks and uncertainties include, without limitation, our history of losses and limited revenue, our ability to develop new products and evolve existing ones, the impact on our business of the recent financial crisis in the global capital markets and negative global economic trends, and our ability to attract and retain key personnel.&#160; For a more complete description of these and other risk factors that may affect the future performance of BIO-key International, Inc., see "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2010 and its other filings with the Securities and Exchange Commission.&#160; Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made.&#160; The Company also undertakes no obligation to disclose any revision to these
forward-looking statements to reflect events or circumstances after the date made or to reflect the occurrence of unanticipated events.</font></div>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>biokeylogo.jpg
<TEXT>
begin 644 biokeylogo.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_X0!F17AI9@``24DJ``@````$`!H!!0`!
M````/@```!L!!0`!````1@```"@!`P`!`````@`!`3$!`@`0````3@``````
M``!@`````0```&`````!````4&%I;G0N3D54('8U+C`P`/_;`$,`#@H+#0L)
M#@T,#1`/#A$6)!<6%!06+"`A&B0T+C<V,RXR,CI!4T8Z/4X^,C)(8DE.5EA=
M7ETX169M95IL4UM=6?_;`$,!#Q`0%A,6*A<7*ED[,CM965E965E965E965E9
M65E965E965E965E965E965E965E965E965E965E965E965E96?_``!$(`)<`
MR@,!(@`"$0$#$0'_Q``?```!!0$!`0$!`0```````````0(#!`4&!P@)"@O_
MQ`"U$``"`0,#`@0#!04$!````7T!`@,`!!$%$B$Q008346$'(G$4,H&1H0@C
M0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U-C<X.3I#1$5&1TA)2E-45597
M6%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJ
MLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X
M^?K_Q``?`0`#`0$!`0$!`0$!`````````0(#!`4&!P@)"@O_Q`"U$0`"`0($
M!`,$!P4$!``!`G<``0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B
M<M$*%B0TX27Q%Q@9&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G
M:&EJ<W1U=G=X>7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>X
MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@`,`P$`
M`A$#$0`_`/1J***0@HHHH`**R]4UZQTL%9I=TO:).6_^M^-<AJ/C"_N25M@M
MK'_L\M^=1*I&)T4L-4J:I:'?3W$-LF^>:.)?5V`K(N?%>DP9`G:8CM&I/Z]*
M\XFFEG<O-(\CG^)V)-)'&\KA(D9V/15&36+KOHCNC@(K6;.VE\<VX_U-G*W^
M\P7_`!JL?'4F?EL$Q[R'_"LBV\,:M<X(MO*4]Y6"_IUK3B\#W3#][=PI_NJ6
M_P`*7-58W3PD-R0>.I>]BG_?P_X5/%XZC/\`K;%U_P!V0'^@I%\"I_%?L?I%
M_P#7H?P*F/DOV'UCS_6J_>F;>#?],T;?QAI4Q`=I83_MI_AFM>UO[2\&;:XB
ME]E8$_E7&R^![I0?*NX7_P!Y2O\`C6;/X9U>T.];<OMZ-"V3_C3YYK=$NAAY
M_!.QZ;17F]GXEU739/+N"TJCK'.#N'X]:Z[2?$MCJ6(]WD3G_EG(>OT/>KC4
MC(YZN%J4]=T;5%%%:',%%%%`!1110`4444`%%%%`!114%W=0V=L\]PX2-!DD
MT`E?1#YYH[>%I9G5(U&2S'`%</K?BZ6X+0:<3%%T,O\`$WT]/YUEZ[KD^KSD
M',=LI^2//ZGWK(KEJ56](GKX?!J/O5-Q6)8DL22>23WJS8V%SJ$WE6L+2-WQ
MT'U/:MG0/#$NI;;BZW0VO;^\_P!/0>]=[:6EO90"&VB6.,=@/Y^M*%)RU9=?
M&1I^[#5G,Z9X+AC`?4)3*W_/-#A?SZG]*Z:VL[>T39;01Q+Z*N*GHKIC!1V/
M*J5IU/B844451D%%%07-Y;VB;[F>.)?5V`S0-)O1$]%8$_B_28B0LDDI_P!A
M#_7%5O\`A-]/S_J+G'KM7_&I]I'N;+#U7]EG0W5G;7D>RY@CE7_:7.*Y?5/!
M<;9DTV4QMU\N0Y'X'J*TK?Q;I,Q`,SQ$_P#/1"/U%;$%Q#<QAX)4E0]T8$4F
MH3'&5:AW1QFFZ_?:-<"RUB.0QC@,W+*/7/\`$*[2&:.XA66%U>-QE64Y!J&_
MT^VU&W,-U$'7L>ZGU![5RB?;/"-X`Y:?2Y6Z_P!T_P!#_.EK#?8MJ%?6*M+M
MW.UHID,J3Q)+$P='&58="*?6AR!1110`4444`%%%%`"$A023@#DFO-O$VMMJ
MEX8XF(M(CA!_>/\`>_PKH_&FJ&UL5LXFQ+<#YL=D[_GT_.O/ZYJT_LH]7`T-
M/:2^05U/A7P[]M*WMXO^CJ?D0_\`+0^I]OYUE^'M*.K:BL39$"?-*1Z>GXUZ
MA&BQ1JB*%11@`=`*5*G?5EXS$<BY([B@```#`'84M%%=1XX4444`%-=E1"SL
M%51DD]!3JYGQK]N>QBBM8W>%B?-V#)]AQVI2=E<NG#GDHWL9^M^,'+M!IF%4
M<&8CD_0?UJCI_AS4=787-Y(\4;<[Y<EV^@K3\*^&]@%[J$7S]8XG'3W(KL:Q
MC!SUF=M2O&C[E%?,PK/PGI=L!OB:X;UE.?T'%:2:981C"65NH]HE_P`*MT5L
MHI;(XY59RW91ET?39AB2QMS[B,`_I69)X7B@D\[2KF:RF'HVY3]0:Z&BAQ3"
M-6<=F8UEJ=Q#<+9:M&L4[<1RK_JY?IZ'VK4N((KJ!X9D#QN,,I[TV\M(;VW:
M"=-R-^8/J/0U7TR651)9W+;YH,8<_P#+1#T;Z\$'W%"TT8.S]Z.C,C2C)H6J
M?V5.Q:TG):VD;L>Z_P"?ZUTU9VMZ>-1T]HU^6=/GB?NKCI4FD7GV_389V&)"
M-LB^C#@C\Z4=-"JCYUS]>I=HHHJC$****`"BBB@#RG7KXZAJ]Q-G*!MB?[HX
M'^/XUG5N:IX:U"SN7$,#SPDY1XQGCW'K4VB^%[N[N5>\A:"V4Y;>,,WL!7"X
MR<MCZ"-:E"FFGH33WEYX5\*07-I:>;/=-ODE925B&/ESCV_K7)Q:]XDUZ_CM
M8;^<S3'"I&WECU[8KU'Q:`OA/4@!@"`X%>7_``^_Y'&R^DG_`*`U=T596/"G
M-SDY/J:-_HWB_1[9KUKZ>1(QN<Q7+,5'J0:U_!?C:>]O(].U4J\DG$4P&"3Z
M-_C7::S<P6FD7<URRK$(FSN[\=/QKQ7PM;2W7B73TA!+"=7..P!R3^0IDG6>
M-;OQ)HU\;@:F5M+B1A"L9QM`[$8J/P;>>)=;OQ*NIDVUNZF82G.X'L!CT!K0
M^+'_`!X:=_UU?^0J/X3']QJG^]'_`":@#J?$WB2U\/6@>4>9<29\J$'!;W/H
M*\]C\1>*O$ETT.GNZCJ4MP$"#W8_XUB^*=4?5]?NK@L3&'*1#T0'`_Q_&O7O
M"NDQZ/H5M"J`2NHDE;N6(Y_+I0!Y_<Z-XUL$-S]HNY,<MY=R7(_#/-6?#WQ"
MNH9TM]:Q+"3CS@N'3Z@=1^M>H5Y)\2M)CL=9BNX$")=J2P`XWCJ?QR/UH`]9
MCD26-9(V#(P!5@<@BG5Q/PRU1KO1YK*5BSVC#:3_`'&S@?@0:[:@14U2>YMM
M.GFL[?[3<(N4BSC<:\G/BS7;G7K=;BY>#;.JM`@V*/FP01W_`!KV.O#=0_Y'
MBX_["!_]&4`>Y57EB/VR"9!R`R-_ND9_F!^=3-(BG#.H/N:%=6^ZP;Z&D-.P
MZLNP3[+JU];CB.7;<(/<\-^HS^-:3ND:%W944=2QP!6<MW:3ZK`]O=V\C"-T
M94E4GDJ1QGV-)CB]T:=%-9U7[S!?J:02(QP'4GT!IDCZ*:SJOWF4?4T*ZL"5
M8''7!H`=13(Y$E7=&ZN.F5.:?0`4444`8WB[_D5=3_ZX-7D_@R*>?Q%%%:R^
M3.\4HCD_NMY;8->L>+O^15U/_K@U>7_#P_\`%8V?^[)_Z`:8RQKGA3Q-';M<
M7DC7L<?)*S%RH]<'FI_A_KVGZ9=_9KJV1)9SM%WG)&>BGT'N/QKUD\CFOGW5
MD2+6;U(<>6D[A,>@8XH`]#^+'_'AIW_75_Y"JWPO)&G:T5^\`F/R:D^(K._A
MW0VESYC#+9]=@S4OPG`-OJH/0M'_`":@#SF`!KF,-T+C/YU]%#H,5X#KE@^E
MZU=VC`CRI"%]UZ@_EBO;M!U!-4T6TNT(/F1C=[,."/SS0!HUP'Q7`_LW3S_%
MYS`?3'_ZJ[^O+/BEJ*3ZE;6,;`_9D+/CLS8X_(#\Z!"_"IMNI:ADX3R`23T^
M]_\`KKTK[;:XS]IAP?\`IH*\[\$>'Y;WPMJKA_*:^7RHF/HO4_0DX_"JW_"L
MM4_Y_;/\V_PH&>GI=6\CA8YXG8]`K@FO$]0_Y'BX_P"P@?\`T976:%\/[_3=
M9M+R:\MS'"X<B/=DX[=*XS6T>7Q7?QQ<2/>.J\XY+G%`&YXU@@U;Q?\`9]),
MMQ=R$)*-V4#`8P/3`'-=IX<\,6OA:":]EN7DE\D^:QX10.3@?A7GGAS4Y/"_
MB1C>PXP3#.&&649Y(_SS7J/B>03^$=0EMG#J]L65E.05QU_*@#S*^U+4/&GB
M"*U5RD4CXBBS\J+ZGU..:O>+/!UOX?TR&\@O7>3>$97`!8^JXK&\)WEQ8:I)
M<6=O]HNE@?RH\9R>,G'?`R:Z6R\*:UXEN5OO$%Q)!$>B-]_'H%Z*/\XH`Q[.
MUNO%&C7D\TTTMYID2^62<B1.25/N,'FH_`=I:WGB6!+J62-D_>1;#C<R\X/X
M9KUW2]*L])M!;64*QQ]3W+'U)[UY!XALY?#/BUFMAL5)!/`>VTG./YB@#I_B
MCI]JL4&H-+(+IR(ECS\I49)..W_UZL>&O"[Z?H(O,RO<W2*TD/8)G(&.YZ$_
MB*R;Z[7QIXRT^"')LHD5F![#[S_T7\*]1RJ@#@`4`8FAV\T<Y9@^T*0[E64/
M]W:,-SQAOS_`;M(#GI2TA!1110!ROCZ+5Y]'$6EQF2)\BX5%RY7MCVZ].:\L
MTJ]N=`UB&\\@B6$G]W(",@C!'Y&O?:CDABE&)8T<>C*#3`\RO_B5=7-JT-G8
M+;RN-OF&3>5^@P.:S_"W@Z]U:]CN+Z%X+%3N8R`@R>P'OZUW7_"0Z1::,FK+
M9&.!YS!\L2A@<D9X[<5K-J]O_:-K9H&D:YA::-UP5*C_`/70,\Y^(6KR:C=K
MIR6,L2V4C#>P^_VX&.E,^'VKRZ5?O9M8S2B]D1=Z@_)C(SC'3G]*[7_A+5^V
M_9/[&U3[1L\SR_*7.W.,_>Z9JQ>>(TMM3DL(M.OKJ:-%=O(12`#T[T`4/&?A
M)=>C%S:E4OHUP-W`D'H??T-<'INJZYX-N'AD@=(V.6AF4[6/J#_45Z=>>(4L
MM-M[R>QO%:XE$*P;!YFXYQQGVI+'7;;4;XZ?<65S:W!3S%CNH@-Z^HY-`'#7
MGQ*U">`QVEG%;R,,;]Q<CZ#_`/75#0?"&IZ]>?:;X2P6SMNDFE&&D]<`]?KT
MKO[#7='ET^_OK:U"?82WFH(U#\=QCUYK3O-8M[+1?[4F#^3L5PH`W'=C`^O-
M`%NUMH;.UBMK=`D,2A54=@*FK*36XY]%AU*TMKFZ27&(HE!<=CD9[8JMI/B5
M-6E*PZ=?1QJ65I9$`12O4$@]:!&EJM\--TV>\,4DPA7=LC&2:\.N+B6;7)-1
M%M(`]P9]F#_>SC->Q+XFL3H,6K,LJPS,4CCVY=VR1@`=^*6P\0P75^EE<6EU
M8W,BEHTN$"^8!UP0>OM0!R?BC2?^$FT2'Q!8VLD-R%/F0L/F=0<9]R,?B*S_
M``;XCGM(AH]]9SW-K.VQ-H.4#<$8[CG^==[9^(K*[GU*",2++IY;S$8#+`9R
M5YY'%6(]7MFT(:N0R6YA\[#`;L8Z?6@9Y7JV@ZIX3UA;RU5W@C??%.JY`'HW
MIZ>];!^)=Y+`(H-,3[4PP&WEAGV7&?UKO-'U>VUG31>VX<1DLK(X&Y2.H-&C
M7=IJ=A'?VD'EI+G&Y`&X)';Z4`8/@BSUL276HZS/,/M(&R&0\CGKC^'TQ5;X
MGZ;'/HT5^"JRVSA>?XE;C'YX/YUW%>3^.M;?7=9ATJP.^"*38,=))#QGZ#I^
M=`B_\/K=-+T2_P!=N%R6'EQCU`Z_FV!^%9FH:A<ZC<--<RLQ)X7/"^P%;WB:
M2/3=+L=#MR,0H&D([_\`ZSDURU<E:5W8]C`T4H\[6K-WPKJ-S;ZO;P+(QAF;
M8R$Y'UKTJO/_``18?:-2>[<?);CCW8__`%LUZ!6M&_+J<F.<?:V04445J<04
M444`>>0V,TGA'3K>6VD;.J@O&R'[F]LDCTQ5G2-.O=-\9V]G(CO96T,OV>8@
MD;&((4GU!R*[JBF!SIAD_P"%@B;RW\K^S=N_:=N?,Z9]:Q=8CC3QA>RW3:K#
M"T$81[$/\Q[@D"MW6M0O=(OXKHDRZ:_RR(%&4/KFMJWGBNH$F@</&XR&'>I4
MDW8MP:2ET9Q^LQ?;]#T:.S;4&07Z`RRJWG*/FRQR.WJ:FTBRFTWQ=*FH&YO6
MDB_T6\D);:O=#V!]_P#&NJN(VE@=$E:)B.'7&5_.L![W6M()%W;C4;<=)HAA
MP/<4.5APAS[/4Y.71[V#PY+?V4$GGR&>WN8=IS)&SG:V/4''X5N:I%J%^-!T
MVSA4^3$EU*9PPCRH`520/7/%:D/B_2I/]8TL+=PZ'C\LU,?%.C@9^UY^D;?X
M4N>/<IT:B^RS.\)I?:;J.H:7?0JJLWVF%H@QC&X_,H)]#CCZU/X0ADBTB^66
M-T8W<Q`92"03P:9<^-;",$6\4TS=N-H_7_"L23Q!K>JW`6Q5XQV2%<_F3_\`
M6J75BMC2.$J2U:LO,+2QO(O">@W2VLLC6%TTTL`7YRN]N0/6M.6Z/B'Q#I+V
M5M<);V+M+--+$4`R,!1GJ:T-&T_5U=9M3U"0XY$*D'\SC^5;]6G<PG%1=D[G
MG4VDWBQ:QJEE"XO(;Z<;"I_?0L`"/?U%6+F"^NO"N@Z-;0$2W"JTWFJP553G
M#$#C)Q^5=[15$'(:%%J.F>(+^VOH8Q'?I]H0VX8QJXX(R1P3UJ+PAK$5AHMI
MI]S;7J7`=E/^C/M&7..<>]=I10`UU#HR-T88-<B_AS0O#+?VJJ2M+%_JE>3(
M+'I@5T]]>P6%LT]RX1%_,GT'O7FFMZO-J]WYC_+$O$<>?NC_`!K*I4Y5YG5A
ML.ZLM=BE=7,EW<R7$S;I)&W$U'&C2R+'&I9V.%`[FFUV_@_03$%U&[3#D?N4
M/8?WJY8Q<V>O6JQHPN;^A::NEZ9'!P9#\TA'=CU_PK1HHKN2LK'@2DY-MA11
M102%%%%`!1110!'/!'<P/#,@>-QAE/>N,D%]X1O"T8:XTV1NA[?X'^==O3)H
MHYXFBE17C88*L,@U,HWVW-:57DT:NGT*NFZI:ZG`)+60-_>4\,OU%7:XC5/#
M-WITYO-&DD(7G8I^=?IZC_/-+IWC.2(^5J<!8C@R(,-^(J54MI(V>&YUS4G=
M?B=9<Z=97?-Q:PR'U9!G\ZHMX8T=CG[&H^CL/ZU:LM7L+\#[/<QLQ_@)PWY&
MKU5:+U,.:I#2[1F1>']*A.5L82?]H;OYUH1QI$H6-%11T"C`I]%4DEL2YREN
MPHHHH)"BD9E5268*!W)K'O\`Q-IED"//\YQ_#%\WZ]*3:6Y482F[15S9K(UC
MQ!9Z4I5F\VXQQ$IY_'TKDM4\77MX"EL/LL1_NG+G\>WX5SK$L2S$DGDD]ZPG
M6_E/0HX!O6I]Q=U35;K5;CS;E^!]U!]U?I5&K-C87.H3"*UA:1N^.@^I[5W6
MA>%8+`K/=[9[D<@?PI]/4^]91A*;N=M2M3H1M^!F>&?##2,EYJ"80<QPMW]S
M[>U=L.*6BNN,5%61XM6M*K+FD%%%%49!1110`4444`%%%%`!1110`5F:IH5C
MJ@)GBVR]I4X;_P"O^-:=%#2>C*C)Q=XL\^U#P;?6Y+6CK<IV'W6'X=*S1?:Q
MI;!&FNH,=%DSC\CQ7J=->-)%*R(KJ>S#(K%T5]EV.R.-E:U17/.8O%^K)]Z2
M*3_>C'],58'C;4>\-L?^`M_C763^'M*N"2]E&I/=,K_*J,G@W2F.5\]/]V3_
M`!!I<E1;,T5?#/>!@/XUU(CY8K9??:?\:J3>*=7F&/M(C'^P@%=-_P`(3IO_
M`#UNO^^U_P#B:4>"M,'62Z/_``,?X5/)5[EJMA5M'\#A+B\N;HYN+B67_?<F
MH>IQ7I,/A/2(SDP/(?\`;D/]*TK;3;*T_P"/>UAC/JJ#/YT>QD]V4\?3CI&)
MYM9:%J5\1Y-JX0_QN-H_6NFT[P5%&0^H3&4_\\X^%_/J?TKKJ*TC1BCDJ8VI
M/1:$-M;06L0BMXDB0=E&*FHHK4XV[[A1110`4444`%%%%`!1110`4444`%%%
H%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`'_V3\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
